{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:56:02Z","timestamp":1773050162588,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112956"],"award-info":[{"award-number":["70112956"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA2530\/6-1"],"award-info":[{"award-number":["MA2530\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Meningioma represents the most common primary brain tumor in adults. Recently several non-<jats:italic>NF2<\/jats:italic> mutations in meningioma have been identified and correlated with certain pathological subtypes, locations and clinical observations. Alterations of cellular pathways due to these mutations, however, have largely remained elusive. Here we report that the Krueppel like factor 4 (<jats:italic>KLF4)-K409Q<\/jats:italic> mutation in skull base meningiomas triggers a distinct tumor phenotype. Transcriptomic analysis of 17 meningioma samples revealed that <jats:italic>KLF4<\/jats:italic><jats:sup><jats:italic>K409Q<\/jats:italic><\/jats:sup> mutated tumors harbor an upregulation of hypoxia dependent pathways. Detailed in vitro investigation further showed that the <jats:italic>KLF4<\/jats:italic><jats:sup><jats:italic>K409Q<\/jats:italic><\/jats:sup> mutation induces HIF-1\u03b1 through the reduction of prolyl hydroxylase activity and causes an upregulation of downstream HIF-1\u03b1 targets. Finally, we demonstrate that <jats:italic>KLF4<\/jats:italic><jats:sup><jats:italic>K409Q<\/jats:italic><\/jats:sup> mutated tumors are susceptible to mTOR inhibition by Temsirolimus. Taken together, our data link the KLF4<jats:sup>K409Q<\/jats:sup> mediated upregulation of HIF pathways to the clinical and biological characteristics of these skull base meningiomas possibly opening new therapeutic avenues for this distinct meningioma subtype.<\/jats:p>","DOI":"10.1186\/s40478-020-00912-x","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:25:53Z","timestamp":1585902353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["KLF4K409Q\u2013mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment"],"prefix":"10.1186","volume":"8","author":[{"given":"Niklas","family":"von Spreckelsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Waldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Poetschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kesseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard","family":"Dohmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ke","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Scherlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Erol","family":"Sandalcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Angenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Krischek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis","family":"Stavrinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Remke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Kirches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Goldbrunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Antonio","family":"Chiocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Huettelmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"Acker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"912_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2005.07.003","volume":"8","author":"T Acker","year":"2005","unstructured":"Acker T, Diez-Juan A, Aragones J, Tjwa M, Brusselmans K, Moons L, Fukumura D, Moreno-Murciano MP, Herbert JM, Burger A et al (2005) Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell 8:131\u2013141. https:\/\/doi.org\/10.1016\/j.ccr.2005.07.003","journal-title":"Cancer Cell"},{"key":"912_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2217\/thy.11.32","volume":"8","author":"C Battelli","year":"2011","unstructured":"Battelli C, Cho DC (2011) mTOR inhibitors in renal cell carcinoma. Therapy 8:359\u2013367. https:\/\/doi.org\/10.2217\/thy.11.32","journal-title":"Therapy"},{"key":"912_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/neuonc\/now276","volume":"19","author":"J Boetto","year":"2017","unstructured":"Boetto J, Bielle F, Sanson M, Peyre M, Kalamarides M (2017) SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Neuro-Oncology 19:345\u2013351. https:\/\/doi.org\/10.1093\/neuonc\/now276","journal-title":"Neuro-Oncology"},{"key":"912_CR4","unstructured":"Chomczynski P, Sacchi N (1987) The single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction: twenty-something years on. Nat Protoc. 1(2):581\u2013585"},{"key":"912_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Av\u015far T, Li J, Murray PB, Henegariu O et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science (New York, NY) 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science (New York, NY)"},{"key":"912_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D (2009) MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:705\u2013710. https:\/\/doi.org\/10.1038\/nature08195","journal-title":"Nature"},{"key":"912_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00701-012-1611-y","volume":"155","author":"JF Cornelius","year":"2013","unstructured":"Cornelius JF, Slotty PJ, Steiger HJ, H\u00e4nggi D, Polivka M, BJAn G (2013) Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases. Acta Neurochir 155:407\u201313. https:\/\/doi.org\/10.1007\/s00701-012-1611-y","journal-title":"Acta Neurochir"},{"key":"912_CR8","unstructured":"Evans PM, Liu C (2008) Roles of Kr\u00fcppel\u2010like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochimica et Biophysica Sinica 40(7):554\u201364."},{"key":"912_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.molcel.2011.11.031","volume":"45","author":"AM Gamper","year":"2012","unstructured":"Gamper AM, Qiao X, Kim J, Zhang L, DeSimone MC, Rathmell WK, YJMc W (2012) Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis. Mol Cell 45:233\u2013243. https:\/\/doi.org\/10.1016\/j.molcel.2011.11.031","journal-title":"Mol Cell"},{"key":"912_CR10","doi-asserted-by":"crossref","unstructured":"Gehring S, Tapia-P\u00e9rez JH, Kirches E, Firsching R, Keilhoff G, Schneider T, Mawrin C (2011) Cytotoxic effects of statins and thiazolidinediones on meningioma cells. J Neurooncol 102(3):383\u201393.","DOI":"10.1007\/s11060-010-0351-1"},{"key":"912_CR11","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383\u2013e391. https:\/\/doi.org\/10.1016\/S1470-2045(16)30321-7","journal-title":"Lancet Oncol"},{"key":"912_CR12","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"B Harsha","year":"2018","unstructured":"Harsha B, Creatore C, Kok CY, Hathaway C, Cole CG, Ramshaw CC, Rye CE, Beare DM, Dawson E, Boutselakis H et al (2018) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941\u2013D947. https:\/\/doi.org\/10.1093\/nar\/gky1015","journal-title":"Nucleic Acids Res"},{"key":"912_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00006123-199607000-00002","volume":"39","author":"B Karlsson","year":"1996","unstructured":"Karlsson B, Kihlstr\u00f6m L, Lindquist C, Mathiesen T (1996) Recurrence of Cranial Base Meningiomas. Neurosurgery 39:2\u20139. https:\/\/doi.org\/10.1097\/00006123-199607000-00002","journal-title":"Neurosurgery"},{"key":"912_CR14","doi-asserted-by":"crossref","unstructured":"Keith B, Johnson RS, Simon MC (2012) HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12(1):9\u201322.","DOI":"10.1038\/nrc3183"},{"key":"912_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL (2015) HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12:357\u201360. https:\/\/doi.org\/10.1038\/nmeth.3317","journal-title":"Nat Methods"},{"key":"912_CR16","doi-asserted-by":"crossref","unstructured":"Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Belldegrun AS (2007) Hypoxia-inducible factor 1\u03b1 in clear cell renal cell carcinoma. Clin Cancer Res 13(24):7388\u2013393.","DOI":"10.1158\/1078-0432.CCR-07-0411"},{"key":"912_CR17","unstructured":"Korkolopoulou P, Patsouris E, Konstantinidou AE, Pavlopoulos PM, KavantzasN, BoviatsisE, Rologis D (2004) Hypoxia\u2010inducible factor 1\u03b1\/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 30(3):267\u201378."},{"key":"912_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"WH Lee","year":"1990","unstructured":"Lee WH (1990) Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27:389\u2013395 discussion 396","journal-title":"Neurosurgery"},{"key":"912_CR19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.stemcr.2017.04.025","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Xian M, Yang B, Ying M, He Q (2017) Inhibition of KLF4 by statins reverses adriamycin-induced metastasis and cancer stemness in osteosarcoma cells. Stem Cell Rep 8:1617\u20131629. https:\/\/doi.org\/10.1016\/j.stemcr.2017.04.025","journal-title":"Stem Cell Rep"},{"key":"912_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics (Oxford, England) 30:923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656","journal-title":"Bioinformatics (Oxford, England)"},{"key":"912_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W (2015) HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B 5:378\u201389. https:\/\/doi.org\/10.1016\/j.apsb.2015.05.007","journal-title":"Acta Pharm Sin B"},{"key":"912_CR22","doi-asserted-by":"crossref","unstructured":"Mel\u00e9ndez-Rodr\u00edguez F, Urrutia AA, Lorendeau D, Rinaldi G, Roche O, B\u00f6\u011f\u00fcrc\u00fc-Seidel N, Hernansanz-Agust\u00edn P (2019) HIF1\u03b1 suppresses tumor cell proliferation through inhibition of aspartate biosynthesis. Cell Rep 26(9):2257\u2013265.","DOI":"10.1016\/j.celrep.2019.01.106"},{"key":"912_CR23","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro-Oncology 19:v1\u2013v88. https:\/\/doi.org\/10.1093\/neuonc\/nox158","journal-title":"Neuro-Oncology"},{"key":"912_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-004-9164-4","volume":"70","author":"S Otsuka","year":"2004","unstructured":"Otsuka S, Tamiya T, Ono Y, Michiue H, Kurozumi K, Daido S, Kambara H, Date I, Ohmoto T (2004) The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neuro-Oncol 70:349\u2013357. https:\/\/doi.org\/10.1007\/s11060-004-9164-4","journal-title":"J Neuro-Oncol"},{"key":"912_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-12-1904","volume":"19","author":"D Pachow","year":"2013","unstructured":"Pachow D, Andrae N, Kliese N, Angenstein F, Stork O, Wilisch-Neumann A, Kirches E, Mawrin C (2013) mTORC1 inhibitors suppress meningioma growth in mouse models. Clin Cancer Res 19:1180\u20131189. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1904","journal-title":"Clin Cancer Res"},{"key":"912_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/jnnp.2009.185074%J","volume":"81","author":"CG Patil","year":"2010","unstructured":"Patil CG, Veeravagu A, Lad SP, Boakye M (2010) Craniotomy for resection of meningioma in the elderly: a multicentre, prospective analysis from the National Surgical Quality Improvement Program. J Neurol Neurosurg Psychiatry 81:502\u2013505. https:\/\/doi.org\/10.1136\/jnnp.2009.185074%J","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"912_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","volume":"14","author":"M Preusser","year":"2018","unstructured":"Preusser M, Brastianos PK, Mawrin C (2018) Advances in meningioma genetics: novel therapeutic opportunities. Nat Rev Neurol 14:106\u2013115. https:\/\/doi.org\/10.1038\/nrneurol.2017.168","journal-title":"Nat Rev Neurol"},{"key":"912_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1215\/15228517-2008-109","volume":"11","author":"J Regelsberger","year":"2009","unstructured":"Regelsberger J, Hagel C, Emami P, Ries T, Heese O, Westphal M (2009) Secretory meningiomas: a benign subgroup causing life-threatening complications. Neuro-Oncology 11:819\u2013824. https:\/\/doi.org\/10.1215\/15228517-2008-109","journal-title":"Neuro-Oncology"},{"key":"912_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss DE, Piro RM, Jones DTW, Simon M, Ketter R, Kool M, Becker A, Sahm F, Pusch S, Meyer J et al (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125:351\u2013358. https:\/\/doi.org\/10.1007\/s00401-013-1093-x","journal-title":"Acta Neuropathol"},{"key":"912_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England) 26:139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616","journal-title":"Bioinformatics (Oxford, England)"},{"key":"912_CR31","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ncb1314","volume":"7","author":"BD Rowland","year":"2005","unstructured":"Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7:1074\u20131082. https:\/\/doi.org\/10.1038\/ncb1314","journal-title":"Nat Cell Biol"},{"key":"912_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1073\/pnas.0509459103","volume":"103","author":"M Safran","year":"2006","unstructured":"Safran M, Kim WY, O'Connell F, Flippin L, Gunzler V, Horner JW, Depinho RA, Kaelin WG Jr (2006) Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci U S A 103:105\u2013110. https:\/\/doi.org\/10.1073\/pnas.0509459103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"912_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/11926","volume":"22","author":"JA Segre","year":"1999","unstructured":"Segre JA, Bauer C, Fuchs E (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22:356\u2013360. https:\/\/doi.org\/10.1038\/11926","journal-title":"Nat Genet"},{"key":"912_CR34","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1074\/jbc.271.33.20009","volume":"271","author":"JM Shields","year":"1996","unstructured":"Shields JM, Christy RJ, Yang VWJJBC (1996) Identification and characterization of a gene encoding a gut-enriched Kr\u00fcppel-like factor expressed during growth arrest. J Biol Chem 271:20009\u201320017","journal-title":"J Biol Chem"},{"key":"912_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"912_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jmcb\/mjx023","volume":"9","author":"HL Tang","year":"2017","unstructured":"Tang HL, Zhu HD, Wang XC, Hua LY, Li JR, Xie Q, Chen XC, Zhang T, Gong Y (2017) KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. J Mol Cell Biol 9:315\u2013324. https:\/\/doi.org\/10.1093\/jmcb\/mjx023","journal-title":"J Mol Cell Biol"},{"key":"912_CR37","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.4238\/vol10-3gmr1212","volume":"10","author":"P Wang","year":"2011","unstructured":"Wang P, Ni RY, Chen MN, Mou KJ, Mao Q, Liu YH (2011) Expression of aquaporin-4 in human supratentorial meningiomas with peritumoral brain edema and correlation of VEGF with edema formation. Genet Mol Res 10:2165\u20132171","journal-title":"Genet Mol Res"},{"key":"912_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130341","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang C, Gu Q, Sims M, Gu W, Pfeffer LM, Yue J (2015) KLF4 promotes angiogenesis by activating VEGF signaling in human retinal microvascular endothelial cells. PLoS One 10:e0130341. https:\/\/doi.org\/10.1371\/journal.pone.0130341","journal-title":"PLoS One"},{"key":"912_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/carcin\/bgi243","volume":"27","author":"D Wei","year":"2005","unstructured":"Wei D, Xie K, Kanai M, Huang S (2005) Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27:23\u201331. https:\/\/doi.org\/10.1093\/carcin\/bgi243","journal-title":"Carcinogenesis"},{"key":"912_CR40","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, HJBcr I (2008) Hypoxia-inducible factor 1\u03b1 is closely linked to an aggressive phenotype in breast cancer. 110:465\u2013475","DOI":"10.1007\/s10549-007-9742-1"},{"key":"912_CR41","unstructured":"Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H (2008). Hypoxia-inducible factor 1\u03b1 is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat, 110(3):465\u201375."},{"key":"912_CR42","doi-asserted-by":"publisher","unstructured":"Yesiloz U, Kirches E, Hartmann C, Scholz J, Kropf S, Sahm F, Nakamura M, Mawrin C (2017) Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1\/2 activation and reduced time to tumor recurrence. Neuro-Oncology 19:1088\u20131096. https:\/\/doi.org\/10.1093\/neuonc\/nox018","DOI":"10.1093\/neuonc\/nox018"},{"key":"912_CR43","doi-asserted-by":"publisher","unstructured":"Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, \u00d6zduman K, Sheth AH, Zhao AY, Tyrtova E, Miyagishima DF et al (2019) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg:1\u201310. https:\/\/doi.org\/10.3171\/2019.8.jns191266","DOI":"10.3171\/2019.8.jns191266"},{"key":"912_CR44","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/onc.2010.591","volume":"30","author":"F Yu","year":"2011","unstructured":"Yu F, Li J, Chen H, Fu J, Ray S, Huang S, Zheng H, Ai W (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30:2161\u20132172. https:\/\/doi.org\/10.1038\/onc.2010.591","journal-title":"Oncogene"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00912-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-020-00912-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00912-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T23:09:50Z","timestamp":1617404990000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-00912-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["912"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-00912-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}